How it All Came Together
Hershko had been with Gordon Tompkins in San Francisco on a post-doctoral fellowship, where he essentially confirmed Simpsons findings but with the tyrosine aminotransferase of cells in cultures. When he returned to Israel to set up his own lab in Haifa he also looked for a cell-free system. I did not meet Avram Hershko until l975, at a Fogerty Conference on Regulation in Bethesda, where we learned of each others interest in protein breakdown. Meanwhile, Tompkins died tragically during a brain tumor operation, and Hershko was looking for a US lab in which to expand his work further during sabbatical years and summers. It is not clear to me why he chose our lab in suburban Philadelphia for this purpose. We had no reputation in protein breakdown, having never published in the field. Our limited expertise was expected to be in mechanistic enzymology. The three American postdocs, Haas, Pickart, and Wilkinson, who came on board for that reason, could not have anticipated the diversion their research careers were about to take.
In l977, when we joined forces at Fox Chase, Etlinger and Goldberg [6] had done the first successful experiment using a cell-free system with lysates of rabbit reticulocytes. Hershko and his student Aaron Ciechanover [7] had already started fractionating the reticulocyte extract and identified the heatstable factor (APF-1) before they came to Fox Chase that summer. Their subsequent work, much of which was reported in collaboration with members of my group, is to be found in the following Nobel Lecture by Hershko. The key observation that the 8-kDa APF-1 formed units of a chain linked to the protein targeted for breakdown was the most unexpected and unique aspect of the process. [8] The identification of APF-1 with ubiquitin was made by three post-docs at Fox Chase: Keith Wilkinson and Arthur Haas from the Rose/Hershko lab and Mike Urban from the neighboring lab. Urban was working with chromatin and knew especially about their interesting components-the histones. [9] The pivotal question asked of Urban was: Do you know any examples of two proteins that are linked covalently. This recalled the small protein of unknown function, ubiquitin, a covalent ligand of histone H2A. The size and amino acid composition of APF-l reported by Hershko and known for ubiquitin were in agreement.
The failure of many cell extracts to give ATP-dependent protein breakdown is probably a consequence of a lysosomal trypsin-like protease that destroys the ubiquitin of the preparation. This was discovered by Haas et al., [10] who observed the loss of enzyme binding capacity of a ubiquitin affinity column when liver extracts were put through it. Haas was able to show ATP/ubiquitin-dependent protein breakdown with liver extracts that were preincubated to inactivate the trypsin-like activity. Ubiquitin was already known to be trypsin-sensitive at the Arg74ÀGly75 bond.
The Ubiquitin Activating Enzyme
Enzymologists usually study the initial rates of reactions by measuring product formation as a function of substrate concentration or another variable. Cell biologists are more likely to want to know the effect of a change on the steadystate behavior of a complex system. When the ubiquitin activating enzyme E1 was discovered by Hershko, it could not be studied by the rate of product formation because the enzyme produced a covalently linked end product. In 1982 Art Haas used isotope exchange at equilibrium to establish the reaction sequence and a number of equilibrium and rate constants of E1-the only enzyme of the cell that uses ubiquitin, per se, as a substrate.
The ubiquitin (Ub) activation process is defined by the formation of two equivalents of pyrophosphate (PP i ), one equivalent of bound AMP-Ub, and two exchange reactions: ATP with PP i and ATP with AMP, as shown in Equations (1)
AMP-Ub, which is prepared from E1, ATP, and Ub and eluted by denaturing the enzyme, is sensitive to both dithiothreitol (DTT) and hydroxylamine, thus indicating an acyl-P-anhydride linkage. The AMP-Ub could be converted back into ATP upon addition of PP i and Mg 2+ ions or to E-SUb, which did not require PP i or Mg 2+ ions. [11] [12] [13] Only the formation of enzyme-bound Ub was inhibited by iodoacetamide, thus indicating transfer to the cysteine of the enzyme (Ub being cysteine-free). The linkage to Ub had already been established to involve the C-terminal glycine of Ub. [14] ATP was shown to precede Ub in combining with E1 and with E1-S-Ub (Scheme 1) since inhibition of ATP/PP i exchange was seen at Ub above 10 mm and inhibition was complete at 400 mm. Addition was not random. [12] Equilibrium constants of the expanded Scheme 1 could be estimated from the influence of varying AMP and PP i on the concentrations of E1-AMP-Ub and E1-S-Ub, which were determined with tritium-labeled ATP by acid precipitation and labeled Ub by electrophoresis. The affinity for ATP (ca. 40 mm) is higher than the level of ATP in the cell, which ensures that the E1 in the cell will be in the E1-ATP or E1-S-Ub-(ATP) form ready to pick up any free Ub (K m = 0.58 mm). The sensitivity to AMP as an inhibitor (K 6 = 0.027 mm) is much higher than ATP as a substrate, which suggests that AMP may be acting as a feedback inhibitor at an allosteric site as well as with E-S-Ub. Here, he learned from Melvin Simpson that protein breakdown was inhibited, not stimulated, under energy-deficient conditions. At Fox Chase , after contributing to enzyme-mechanism research, he was joined by the Hershko/Cienhover team in 1977 who were making progress fractionating reticulocyte extracts. He and his students contributed to studies of the ubiquitin activating enzyme, ubiquitin carrying protein, and ubiquitin C-terminal hydrolase leading to the isolation of ubiquitinaldehyde and an understanding of the hydrolase mechanism. Scheme 1. Sequence and distribution of enzyme intermediates in the activation by ubiquitin.
Ubiquitin-Carboxy-Terminal Hydrolase: Discovery and Mechanism
It was observed that the usual one-turnover assay of E1 used ATP well beyond expectation when glutathione was included in the assay. The explanation: The ubiquitin of E1-SUb is readily transferred nonenzymatically to mild nucleophiles such as glutathione, DTT, and hydroxylamine. By itself, this would increase the consumption of ATP to the amount of Ub present in the assay. However, much more was taken up. Were the Ub derivatives unstable? None of the expected Ub-S-DTT from an incubation of AMP-Ub and DTT could be isolated on a covalently bound Hg + column unless great care was taken in the conversion. Most revealingly, the yield was increased if urea was added immediately after the reaction. This result indicated that an enzyme carried over with the AMP-Ub from the E1 preparation was regenerating the Ub. These two observations-the transfer of Ub from E1-S-Ub to mild nucleophiles and an enzyme contaminating E1 that would restore free Ub-were needed to explain why much more ATP was consumed than could have been expected in the E1 assay. [15] The combined action of E1, glutathione, and the hydrolase results in a futile cycle converting ATP into AMP + PP i (Scheme 2). AMP-Ub is normally too tightly bound to E1 to lead to a futile cycle of its own in the presence of an active nucleophile.
Amides of ubiquitin were not available to test as substrates of the new ubiquitin thioesterase until their synthesis was made possible by Cecile Pickart through the action of E1 + E2 on primary amines. [16] This research was of great interest because the enzymes required for recovery of Ub from conjugation in the newly emerging Ub system were believed to be isopeptidases. An E1·E2-S-Ub complex normally transfers Ub to the e-NH 2 group of lysine in proteins. To determine the substrate specificity of this system, Dr. Pickart found that a variety of small primary amines at much higher concentration are also very good Ub acceptors. The Ub amides were good substrates for the previously purified Ub thiolesterase which henceforth has been known as ubiquitin-carboxy-terminal hydrolase (UCH).
The pure enzyme (M w = 29 kDa) was readily prepared from mature human red cells (ca. 0.1 units per mL of packed cells). Its turnover rate is quite high, almost diffusion limited, and its V max value is approximately 10 s À1 . Ubiquitin conjugated to glutathione or to a polyamine in cells with such activity should be negligible.
The rate of the E1·E2/UCH/amine system can be determined by measuring ATP consumption in a futile cycle similar to that of Scheme 2, where the rate can be used to test the activity or the specificity of the component present in a rate-determining amount. UCH enzymes are limited in the size of the substrate they will act upon. Any role in the deubiquitination of polyubiquitin chains is doubtful. This activity is given over to much larger deubiquitinating enzymes (DUBs).
Considerations of the mechanism of UCH start with the observation that these enzymes are inactivated by iodoacetamide, protected by Ub, and therefore should have an activesite thiol group and possibly a ubiquitin thiolester intermediate. We found that inactivation of UCH was brought about by borohydride if ubiquitin was also present. [17] Both the tritium from the borohydride and the label from Ub were tightly fixed to the inactive enzyme. Both isotopes were released upon mild acid denaturation, whereby tritium traveled with the Ub. The released product was about 1000 times more inhibitory than Ub in an assay using [ 3 H]-butanol-4-NH 2 -Ub as a substrate. This effect was lost with borohydride addition to the inhibitor, which was protected from reduction if enzyme was added first. We concluded that the acid-liberated inhibitor must be the C-terminal aldehyde form of Ub (Ubal). This was shown with [ 3 H]-NaBH 4 , and by isolation of [ 3 H]-ethanolamine among the acid-hydrolysis products. The basis for the protection of the Ubal by the enzyme must be the formation of a strong complex that shields the aldehyde group. A combination of chemical and physical forces would result from the addition of the active-site SH to the carbonyl group, a thiolhemiacetal on the one hand and multiple protein-protein interactions between the active site and the remainder of the Ubal. Additional stabilization may come from the resemblance of the thiohemiacetal to the tetrahedral intermediates and transition states in the amidase reaction, as would be drawn for papain and cathepsin B (Scheme 3).
This interpretation of the mechanism of action of Ubal has been confirmed and extended by X-ray crystallographic studies of Ubal complexed with the UCH of yeast Yuh 1 by Johnston et al. [18] and with the 352-residue UCH domain that was cut out of the 1102-residue-long HAUSP (herpes virus preassociated ubiquitin-specific protease) deubiquitinating enzyme by Hu et al. [19] In both cases, Ubal caused significant distance and angle rearrangements in the catalytic triad regions compared with structures obtained without Ubal, [19, 20] respectively, as well as placement of H-bonding residues to accommodate the expected oxyanion hole of a thiohemiacetal-Ub adduct.
The large DUBs, about 80 of which have been identified, serve to reverse the lengthening of the polyubiquitin chains that leads to the destruction of the targeted protein at the proteasome. HUASP is also known as a tumor-suppressor coprotein because deubiquitinating p53 (the tumor suppressor 
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Angewandte Chemie transcription factor of tissues) should raise its steady-state level. The large size of DUBs is consistent with high specificity and signal control. The roles of the UCHs are not yet clear. The size of the Ub extension that can be removed by these smaller enzymes is smaller than a Ub molecule so that Ub-Ub cleavage intermediates, if they arise in the deubiquitination process, will not be further degraded by a UCH.
Unresolved Issues
* Current discussions of the E1-E2-E3 system often ignore the potential of E1-AMP-Ub to transport Ub units between the solvent and E1-SH to E2 without dissociation of the E1·E2 complex. This possibility should be easily evaluated by pulse/chase experiments using heavy-isotope-labeled Ub in the pulse, unlabeled Ub in the chase, and analyzing the product by mass spectrometric sequencing. * This approach may fail if the E2·E3-protein interactions are weak. In addition, the experiment should give information about the processivity of the system, namely, how many Ub moleculess can be added in succession. * This approach should also answer the question of whether when Ubs are added to the growing chain they are added to the distally located end of the chain as is often stated, but which seems unreasonable as the chain-length increases. * An interesting problem stems from the observation by Cecile Pickart [16, 17] that hydroxylamine at K m % 1 mm inactivates the C-terminal hydrolase of erythrocytes, and possibly all UCHs, in the presence of Ub. Using the hydroxamate of Ub as a substrate, complete inactivation requires about 2000 turnovers of the enzyme. Labeled Ub is not found on the re-isolated enzyme, nor is activity recovered. Unless hydroxylamine has some unexplored way of reacting with the S-of the Ub-thiolester-enzyme intermediate, the classical reaction products should be Ub-hydroxamate and active enzyme. In view of the important role of the deubiquitinating enzymes and a practical interest in their inactivation, it will be useful to know how hydroxylamine works.
It is a pleasure to pay tribute to Dr. Avram Hershko whose analytic intuition was always productive and whose generous spirit made our interactions always harmonious. His graduate student Aaron Ciechanover played an important role in communicating the progress made in Israel to those at Fox Chase. He has continued adding many fundamental observations to the field. The post-docs: Aaron Ciehanover, Art Haas, Cecile Pickart, and Keith Wilkinson were all major contributors, who have continued their careers in the Ub field with notable success. Thanks are also due to Hannah Heller and Jesse Warms for their contributions in the lab.
